INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 428m ago
House PTR28m ago
SEC 13F27m ago
Robinhood Chain27m ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

66,143 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
NG
Noles Russell GDirector
JXNJackson Financial Inc.
Grant or award
A—
156 sh
Sep 24, 2026Sep 28, 2026
Page 257 of 1654
← PrevNext →
traded Sep 24, 2026
+4d
SEC Form 4

Evidence

9
AW
Ackles Robert WilliamChief People Officer
ADRXADARx Pharmaceuticals, Inc.
Grant or award
A—
85.3K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
TN
Truban Erica N.Director
FMBMF&M BANK CORP
Grant or award
A$4,120
102 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
AA
Anderson Craig A.SVP and Controller
JXNJackson Financial Inc.
Grant or award
A—
24 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
SE
Sanderson Katherine ElizabethSee Remarks
CDWCDW Corp
Tax withholding
F$36K
232 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
KE
Kim Sarah EEVP, CLO & Corporate Secretary
SPCEVirgin Galactic Holdings, Inc
Tax withholding
F$73.6
23 sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

9
SE
Stecher Esta EDirector
JXNJackson Financial Inc.
Grant or award
A—
355 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
MP
Mawer Stephen PDirector
CLMTCalumet, Inc. /DE
Option exercise
M—
61.4K sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

9
SA
Stauderman Kenneth A.Chief Scientific Officer
CALCCalciMedica, Inc.
Grant or award
A—
180.0K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
HA
Houff Neil A.Director
FMBMF&M BANK CORP
Grant or award
A$6,180
153 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
TH
Ting Jerry HaoDirector
ASANAsana, Inc.
Grant or award
A—
38.8K sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

9
BS
Boenisch SandraPFO & Treasurer
AVXLANAVEX LIFE SCIENCES CORP.
Grant or award
A—
25.0K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
PL
Prieskorn Laura LoueneDirector, CEO and President
JXNJackson Financial Inc.
Grant or award
A—
208 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
CA
Chakravarthy ArthiChief Legal Officer
ENVXEnovix Corp
Tax withholding
F$6,574
2,221 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
FR
Fisk RyanCFO and CBO
ADRXADARx Pharmaceuticals, Inc.
Grant or award
A—
170.7K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
LJ
Lippert Martin JDirector
JXNJackson Financial Inc.
Grant or award
A—
329 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
MJ
Morical Gregory JSVP, GENERAL COUNSEL
CLMTCalumet, Inc. /DE
Option exercise
M—
30.7K sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

9
LZ
Li ZhenDirector, President and CEO, 10% Owner
ADRXADARx Pharmaceuticals, Inc.
Grant or award
A—
1.02M sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
CC
Chelko CarrieEVP and General Counsel
JXNJackson Financial Inc.
Grant or award
A—
40 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
BP
Binioris Savvas Steve PanagiotisEVP and Chief Risk Officer
JXNJackson Financial Inc.
Grant or award
A—
34 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
MR
MacLeod Alan RobertChief Scientific Officer
ADRXADARx Pharmaceuticals, Inc.
Grant or award
A—
170.7K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
CF
Claffee Lily FuDirector
JXNJackson Financial Inc.
Grant or award
A—
329 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
AA
Anderson Craig A.SVP and Controller
JXNJackson Financial Inc.
Grant or award
A—
20 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
RJ
Russo Joseph J.EVP&Pres-Global Networks&Tech
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,104
82 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
SA
Srinivasan AnithaCHIEF FINANCIAL OFFICER
TRTTRIO-TECH INTERNATIONAL
Option exercise
M—
8,005 sh
Sep 28, 2026Sep 28, 2026
traded Sep 28, 2026
+0dSEC Form 4

Evidence

9
MD
Malone Mary Alice Dorrance JRDirector, 10% Owner
CPBCAMPBELL'S Co
Grant or award
A—
2,155 sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

9
DF
Demartino Emilee F.Executive Vice President
KRKROGER CO
Grant or award
A—
12.8K sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

9
HS
Hebbar SudarshanChief Medical Officer
CALCCalciMedica, Inc.
Grant or award
A—
180.0K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
VV
Venkatesh VandanaEVP and Chief Legal Officer
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,277
95 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
BS
Bardin StephenChief Financial Officer
CALCCalciMedica, Inc.
Grant or award
A—
190.0K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
SE
Sweeney Susan ESee Remarks
TGTREDEGAR CORP
Grant or award
A—
8,343 sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

9
BT
Borgmann Louis ToddCHIEF EXECUTIVE OFFICER
CLMTCalumet, Inc. /DE
Option exercise
M—
107.4K sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

9
LD
Lawton DrewDirector
JXNJackson Financial Inc.
Grant or award
A—
208 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
KG
Kirkland Derek GDirector
JXNJackson Financial Inc.
Grant or award
A—
103 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
CW
Cummings Don WEVP and CFO
JXNJackson Financial Inc.
Grant or award
A—
21 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
CW
Cummings Don WEVP and CFO
JXNJackson Financial Inc.
Grant or award
A—
45 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
BP
Binioris Savvas Steve PanagiotisEVP and Chief Risk Officer
JXNJackson Financial Inc.
Grant or award
A—
41 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
AA
Anderson Craig A.SVP and Controller
JXNJackson Financial Inc.
Grant or award
A—
3 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
AA
Anderson Craig A.SVP and Controller
JXNJackson Financial Inc.
Grant or award
A—
11 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
LW
Lassiter Wright IIIDirector
FTVFortive Corp
Small acquisition
L$300
5 sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. BUYMTDRMatador Resources CoNov 5 – Nov 56 insiders$507K
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K